NYSE · BKKT.WS

Bakkt, Inc.. to purchase Each entitles to purchase 1/25th of a of at an exercise price of $287. 50 for one of

$0.04 $0.00 (+0.00%) 1D Market open

Key Metrics

$286.98K
Market cap
P/E · TTM
$1.26B
Revenue · TTM
−$126.57M
Net income
EPS · TTM $-17.64
Dividend yield
Free cash flow
Beta · 1Y 1.05
EBITDA · TTM −$145.79M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 13
    From its Feb 20 high, the share price fell 75%.

    Peak close $0.16 on Feb 20; trough close $0.04 on Jul 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -75%
  • Jun 11
    The stock moved +56.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 11
  • May 5
    The stock moved +51.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.04 – $0.55
Avg volume · 20D97.3K
Net cash
Book value / share$23.82
IndustryFinance Services
ExchangeNYSE
About Bakkt, Inc.. to purchase Each entitles to purchase 1/25th of a of at an exercise price of $287. 50 for one of
IPO dateOct 18, 2021
Employees48

Bakkt Inc builds digital financial infrastructure designed to support institutional participation in the digital asset economy.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.00
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -11.6%
Net -10.0%
FCF
ROE / ROIC -123.6% · -160.8%

Financial Health

Current ratio4.13
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$94.72M

Cash Flow · TTM

Operating CF −$64.21M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-1.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings